This site is intended for health professionals only
Tuesday 22 January 2019
Share |

Hazardous products

Hazardous products

Latest hazardous products news

25.09.15: Daratumumab is for treatment of European patients with heavily pre-treated multiple myeloma
09.09.15: Daratumumab is for European patients with heavily pre-treated multiple myeloma
26.06.15: Adults with non-radiographic axial spondyloarthritis can be considered for once-monthly subcutaneous...
10.06.15: The comparable safety and efficacy of switching patients to a biosimilar anti-TNF-alpha monoclonal antibody...
03.03.15: • The European Medicines Agency has determined that Remsima, a biosimilar, is comparable to the reference...

Hazardous products analysis

Tuesday 24 July 2012
Some worrying observations were highlighted during a satellite seminar sponsored by Fresenius Kabi, discussing safety...

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine